You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GLP-1 analog

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Volunteers Trial in Knoxville (SHP681, Placebo)

Completed
Has Results
  • Healthy Volunteers
  • Knoxville, Tennessee
    New Orleans Center for Clinical Research
Feb 8, 2021

Morbid Obesity, Metabolic Syndrome, Diabetes Trial in Columbia (GLP-1 receptor agonist)

Not yet recruiting
  • Morbid Obesity
  • +4 more
  • GLP-1 receptor agonist
  • Columbia, Missouri
    University of Missouri Hospital
Nov 20, 2023

Obesity Trial in Hamburg (GLP-1 (Liraglutide), Placebo)

Terminated
  • Obesity
  • GLP-1 (Liraglutide)
  • Placebo
  • Hamburg, Germany
    University Medical Center Hamburg
Jun 29, 2022

Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists

Not yet recruiting
  • Gastric Ultrasound
  • +2 more
  • Gastric Ultrasound Exam
  • (no location specified)
Aug 15, 2023

Four Second Line Pharmacological Strategies in Type 2 Diabetes

Active, not recruiting
  • Cardiovascular Events
  • +2 more
  • SGLT2 inhibitor
  • +3 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Feb 17, 2022

Effects of GLP-1 Agonists on Gastric Volume

Not yet recruiting
  • Diabetes
  • +3 more
  • Gastric Ultrasound
  • Charleston, South Carolina
    Medical University of South Carolina
May 10, 2023

Gastric Volume in Patients on GLP-1 Medications

Recruiting
  • Diabetes
  • None - observational
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jun 6, 2023

Polycystic Ovary Syndrome Trial in Shanghai (GLP-1 RAs, calorie restricted diet)

Completed
  • Polycystic Ovary Syndrome
  • GLP-1 RAs
  • calorie restricted diet
  • Shanghai, Shanghai, China
    Shanghai Tenth People' Hospital
Aug 2, 2022

Incidence of Retained Gastric Food on Endoscopy

Not yet recruiting
  • Gastric Content Aspiration
  • Esophagogastroduodenoscopy
  • (no location specified)
May 16, 2023

GLP-1, Gut Microbiota Trial in Mexico City (sucralose, )

Recruiting
  • GLP-1
  • Gut Microbiota
  • sucralose
  • placebo
  • Mexico City, Mexico
    Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubi
Oct 17, 2023

Diabetes, Type 2 Treated With Insulin Trial in Bogotá (insulin degludec + liraglutide, Insulin Glargine - Insulin Aspart)

Recruiting
  • Diabetes Mellitus, Type 2 Treated With Insulin
  • insulin degludec + liraglutide
  • Insulin Glargine - Insulin Aspart
  • Bogotá, Colombia
    Hospital Universitario San Ignacio
Mar 2, 2023

Delayed Gastric Emptying, Gastroparesis Trial in Chapel Hill (gastric ultrasound)

Not yet recruiting
  • Delayed Gastric Emptying
  • Gastroparesis
  • gastric ultrasound
  • Chapel Hill, North Carolina
    University of North Carolina Medical Center
Sep 8, 2023

Diabetes Trial in Nanjing (Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc)

Recruiting
  • Diabetes
  • Duragtide, Semaglutide, losenatide, tirzepatide, ebenatide, etc
  • Nanjing, China
    Nanjing First Hospital, Nanjing Medical Univesity
Aug 6, 2023

Type II Diabetes Trial in Dijon (drug, procedure, other)

Recruiting
  • Type II Diabetes
  • GLP-1 agonists
  • +2 more
  • Dijon, France
    Chu Dijon Bourgogne
Jan 2, 2023

Obesity, Liver Diseases, Liver Fibrosis Trial in Boston (ESG, GLP1-RA)

Not yet recruiting
  • Obesity
  • +16 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Nov 14, 2023

Type 2 Diabetes, Diabetes, Type 2 Trial (Tirzepatide)

Not yet recruiting
  • Type 2 Diabetes
  • Diabetes Mellitus, Type 2
  • (no location specified)
Feb 6, 2023

Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1

Not yet recruiting
  • Overweight and Obesity
  • 24-hour ambulatory blood pressure
  • Liberal salt diet
  • (no location specified)
Oct 4, 2023

GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • Myocardial Infarction
  • PCI
  • Naples, Italy
    Celestino Sardu
Aug 31, 2023

Glucagon-like Peptide-1 Receptor Agonists According to Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • GLP-1 receptor agonist
  • Bari, Italy
    Azienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023

GLP-1 Receptor Agonists on Efficacy and Persistence, Adherence

Completed
  • Type 2 Diabetes
  • Obesity
  • Valencia, Spain
    INCLIVA
Sep 6, 2022

Obesity Trial in Singapore (Endoscopic sleeve gastroplasty)

Not yet recruiting
  • Obesity
  • Endoscopic sleeve gastroplasty
  • Singapore, Singapore
    Sengkang General Hospital
Oct 4, 2022

Semaglutide Use in Acute Pulmonary Embolism

Completed
  • Pulmonary Embolism
  • London, United Kingdom
    Colm McCabe
Nov 3, 2023

Preoperative Prandial State of Patients Taking Glucagon-Like

Recruiting
  • Pulmonary Aspiration
  • Gastric ultrasound
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jun 6, 2023

Cystic Fibrosis, Cystic Fibrosis-related Diabetes Trial in Minneapolis (Semaglutide)

Not yet recruiting
  • Cystic Fibrosis
  • Cystic Fibrosis-related Diabetes
  • Minneapolis, Minnesota
    University of Minnesota
Mar 15, 2023

Osteoporosis, Postmenopausal, Diabetes, Type 2 Trial in Jackson (GLP-1 receptor agonist)

Recruiting
  • Osteoporosis, Postmenopausal
  • Diabetes Mellitus, Type 2
  • GLP-1 receptor agonist
  • Jackson, Mississippi
    University of Mississippi Medical Center
Aug 5, 2022